Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:TORC

resTORbio (TORC) Stock Price, News & Analysis

resTORbio logo

About resTORbio Stock (NASDAQ:TORC)

Advanced Chart

Key Stats

Today's Range
$0.72
$0.77
50-Day Range
$2.28
$14.77
52-Week Range
$0.86
$10.50
Volume
197,088 shs
Average Volume
1.15 million shs
Market Capitalization
$26.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TORC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for resTORbio and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TORC Stock News Headlines

Adicet Bio Inc (ACET)
Take a look at this picture ...
A strange investment secret — discovered just a few short weeks before this image was taken — correctly predicted it all. Even crazier, this secret accurately called every major financial event in recent history … Now it's signaling something very scary is about to hit the market again …tc pixel
TinOne Resources Inc. (TORC.V)
See More Headlines

TORC Stock Analysis - Frequently Asked Questions

resTORbio, Inc. (NASDAQ:TORC) issued its earnings results on Thursday, July, 30th. The company reported ($0.15) EPS for the quarter, beating the consensus estimate of ($0.22) by $0.07.

resTORbio (TORC) raised $86 million in an initial public offering on Friday, January 26th 2018. The company issued 5,700,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch, Leerink Partners and Evercore ISI acted as the underwriters for the IPO and Wedbush PacGrow was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that resTORbio investors own include Novavax (NVAX), VBI Vaccines (VBIV), AbbVie (ABBV), Dynavax Technologies (DVAX), SCYNEXIS (SCYX), Sorrento Therapeutics (SRNE) and CRISPR Therapeutics (CRSP).

Company Calendar

Last Earnings
7/30/2020
Today
8/29/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:TORC
CIK
1720580
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.41)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$82.74 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-78.12%
Return on Assets
-71.63%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
20.69
Quick Ratio
20.69

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.24 per share
Price / Book
0.34

Miscellaneous

Outstanding Shares
36,454,000
Free Float
N/A
Market Cap
$27.65 million
Optionable
Not Optionable
Beta
2.43
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:TORC) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners